Skip to content
BALCAO · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · SMALL CAP

Weed, Inc. BUDZ

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$0
$-1.4M
$-236,536

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 0.00
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.0 · Net income -1.4
-15M-30M
20102018202120242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
ROE
FY2023 · ROE -14.8%
-500%-1000%-1500%
201020202025
Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -0.2
-2M-3M
201020202025

Total assetsUSD 559,906.00
EquityUSD -688,361.00
CashUSD 33,130.00
Current ratio0.04×

Equity funds -123% of total assets.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
BUDZ, 11-year financial record
Metric 20252024202320222021202020192018201720112010
Revenue $B0.00.00.00.0◌0.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.00.00.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.0◌◌◌◌◌
Income tax $B0.00.00.00.0◌◌◌◌◌◌◌
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.00.00.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−0.01−0.00−0.00◌−0.02−0.04−0.26−0.28−0.030.170.04
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————————
ROE %——−14.8−388.2−379.1−390.6−1389.9−1878.1−966.6——
Shares out B0.150.130.120.120.120.110.110.110.100.010.01

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 48 reconciliationsAUDITED

Reconciled in 11 of the 11 fiscal years we could check. 15 checks were skipped: cost of revenue is not tagged before 2022. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: EPS is not tagged before 2010.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Commercial Physical & Biological Research
Listed onOTC market
Incorporated inNevada
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image